Redefine health, realize longevity

We invest in the future of medicine.

Through cross-disciplinary innovation, we integrate biotechnology, AI diagnostics, and regenerative science to build a smarter, healthier world.

From precision medicine to global medical access, our mission is to connect advanced healthcare solutions with every life that seeks renewal and resilience.

A New Era of Trading Technology: Empowering Members to Trade with Precision and Confidence

Today, BC officially announces a groundbreaking service upgrade: the platform will introduce a top-tier AI Trading Expert Team powered by advanced algorithms, while simultaneously granting members full pre-market trading access. This milestone aims to bring institutional-grade research capabilities to individual investors, enabling them to capture market trends with precision through a deep fusion of human insight and artificial intelligence.

Read More »

BC Capital Healthcare

We are committed to creating lasting impact by advancing biotechnology, regenerative medicine, and AI-driven healthcare solutions that improve human life.

Through continuous innovation and cross-disciplinary collaboration, we aim to redefine what it means to live healthier, longer, and more sustainably.

Partnering differently

We collaborate with visionaries, clinicians, and innovators who share our belief in a smarter, longer, and healthier future.

By bridging research, technology, and cross-border medical ecosystems, we build partnerships that transform scientific potential into measurable human impact.

Unlocking opportunity

We unite biotechnology, AI-driven diagnostics, and regenerative sciences to unlock new dimensions of human health.

Through a culture of collaboration and relentless pursuit of progress, we turn today’s discoveries into tomorrow’s medical breakthroughs.

Creating exceptional outcomes

We pursue exceptional outcomes by empowering innovation and advancing medical frontiers.

Through data intelligence, precision science, and global collaboration, we continuously challenge the limits of what’s possible — turning breakthrough research into tangible health impact.

Our Integrated Platform

Over the past decade, we have built an integrated healthcare innovation platform that connects science, data, and global capital.

Our mission is to accelerate medical progress through intelligent collaboration — uniting biotechnology, artificial intelligence, and precision health investment into one continuous ecosystem.

Biomedical Innovation
AI & Data Intelligence
Longevity & Regenerative Science
Global Medical Access
Investment
Biomedical Innovation
Unleash the power of cutting-edge technology.

Vertical Spotlight

Technology

Leading breakthroughs for a smarter world.

From AI-powered diagnostics to data-driven biotechnology, we drive transformative technologies that redefine healthcare precision and efficiency. Our technology division empowers researchers, clinicians, and investors to unlock new possibilities in life science and medical intelligence.

Healthcare

Building better systems to serve life.

We integrate advanced medicine, regenerative therapy, and personalized care into a global platform for longevity and wellness. By combining clinical excellence with sustainable innovation, we build the infrastructure that helps humanity live longer, healthier, and more resilient lives.

Ethical Innovation & Governance

Ensuring all technologies and medical research adhere to global ethical, data, and safety standards

Promoting low-carbon labs, clean manufacturing, and environmentally responsible healthcare infrastructure.

Fair Growth & Human Well-being

Creating sustainable employment, diversity, and a safe environment for scientists and partners worldwide.

Global Health Equity

Expanding access to advanced medical technology and preventive care in underserved regions.

Community Empowerment

Partnering with universities, hospitals, and local innovators to build education and health ecosystems that last.

Latest News

Stay informed with our latest announcements, global partnerships, and innovation milestones driving the future of intelligent healthcare and biotechnology.

Today, BC officially announces a groundbreaking service upgrade: the platform will introduce a top-tier AI Trading Expert Team powered by advanced algorithms, while simultaneously granting members full pre-market trading access. This milestone aims to bring institutional-grade research capabilities to individual investors, enabling them to capture market trends with precision through a deep fusion of human insight and artificial intelligence.
On June 18, 2025, we are thrilled to announce that the BC Investment Platform has officially launched its pre-market trading feature along with primary market account services! This major upgrade is our special gift to all members, enabling you to break through traditional trading time limits, position earlier, and capture fleeting market opportunities.

PRESS RELEASE / Biotechnology

LongevityX Completes $800 Million Series C Financing to Advance Regenerative and Genetic Therapies

LongevityX announced the completion of its $800 million Series C round, accelerating breakthroughs in regenerative medicine, stem cell rejuvenation, and anti-aging genetic therapy across Asia, Europe, and the U.S.

PRESS RELEASE / AI Healthcare

MedAI Systems Launches Global Diagnostic Platform Integrating Real-Time Imaging and Predictive Analytics

The platform combines multi-modal medical imaging, genetic data, and AI-based analytics to enhance precision diagnosis and personalized treatment planning.

PRESS RELEASE / Investment & Innovation

Heliova Capital Expands $1.2 Billion Green Biotech Fund for Sustainable Health Initiatives

Heliova Capital announced the expansion of its dedicated green biotechnology investment fund, focusing on low-carbon pharmaceuticals, clean medical manufacturing, and sustainable healthcare infrastructure.

PRESS RELEASE / Global Partnerships

Genetica and Corelium Form Strategic Alliance to Build AI Genomic Intelligence Network

The collaboration aims to create a global genomic data ecosystem, integrating AI-driven analysis and blockchain-based privacy protection for next-generation precision medicine.

Our Global Presence

From North America to Asia-Pacific and Europe, our global presence reflects a unified vision — to make advanced healthcare and biotechnology accessible to all.

We collaborate with world-class research centers, hospitals, and technology partners across major innovation hubs, creating an integrated ecosystem that drives medical excellence worldwide.

Denver, USA
Headquarters for research
and AI development

New York, USA
Investment & capital
operations center

Toronto, Canada
AI healthcare analytics hub

Zurich, Switzerland
Longevity and regenerative
medicine research

London, UK
Capital strategy and
biomedical innovation

Berlin, Germany
Biotechnology and molecular
data research

Singapore
Regional hub for clinical
innovation and R&D

Tokyo, Japan
Advanced diagnostic and
imaging technology center

Seoul, Korea
Precision medicine and AI
data collaboration lab

Shanghai, China
Global partnership and
biotech acceleration center

Sydney, Australia
Life science investment and
research expansion